AUSPEX PHARMACEUTICALS INC - COM (ASPX)

CUSIP: 05211J102

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
19,021,598
Share change
+3,694,237
Total reported value
$1,907,306,749
Put/Call ratio
8.8%
Price per share
$100.27
Number of holders
138
Value change
+$439,344,390
Number of buys
106
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP 05211J102?
CUSIP 05211J102 identifies ASPX - AUSPEX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUSPEX PHARMACEUTICALS INC - COM (ASPX) as of Q1 2015

As of 31 Mar 2015, AUSPEX PHARMACEUTICALS INC - COM (ASPX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,021,598 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, FMR LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, FRANKLIN RESOURCES INC, JANUS CAPITAL MANAGEMENT LLC, ALPINE ASSOCIATES MANAGEMENT INC., WATER ISLAND CAPITAL LLC, and JPMORGAN CHASE & CO. This page lists 138 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.